Roche Venture Fund | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Roche Venture Fund/Activity

Roche Venture Fund Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

4 investments· MAY 2023 – APR 2026Show all

Investment

Roche Venture Fund invested in EpiBiologics, developer of bispecific antibodies for targeted protein degradation.

EpiBiologics

EpiBiologics Roche Venture Fund

epibiologics.comAPR 2026

APR 2026

Investment

Participated in COUR Pharmaceuticals' $105M Series A financing for immune-tolerance therapeutics, co-led by Lumira Ventures and Alpha Wave Ventures.

Cour

Cour Roche Venture Fund

globenewswire.comJAN 2024

JAN 2024

Investment

Participated in Mironid's Series A extension, raising $35M to date for ADPKD small-molecule therapeutics.

Mironid

Mironid Roche Venture Fund

mironid.comSEP 2023

SEP 2023

Investment

Participated in DiogenX's EUR 27.5M Series A financing for diabetes biologics.

DiogenX

DiogenX Roche Venture Fund

diogenx.comMAY 2023

MAY 2023

Exit

Portfolio company lino Biotech was acquired by a Germany-based company.

lino Biotech

lino BiotechRoche Venture Fund

startupticker.chMAR 2023

MAR 2023